LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Immunoassay Accurately Measures Serum Hepcidin-25

By LabMedica International staff writers
Posted on 08 Nov 2010
An enzyme linked immunoassay assay (ELISA) can precisely measure the concentration of hepcidin-25 in serum.

Hepcidin is a key regulator of iron metabolism deficiency has been linked to hemochromatosis and iron overload, while increased concentrations are found in anemia of malignancy and chronic diseases.

Hepcidin-23 is the active form of the protein that binds to the iron transporter ferroportin to cause its degradation. A sandwich ELISA test using two antihepcidin-25 monoclonal antibodies was compared with the liquid chromatography-mass spectrometry (LC-MS) method. One hundred serum samples from healthy volunteers (ages 18–64 years, mean age 37 years) with a broad ethnic range and an equal number of male and females, and 34 serum samples from cancer patients were tested at the Lilly Research Laboratories, (Eli Lilly and Company; Indianapolis, IN, USA).

The sandwich ELISA was highly specific for hepcidin-25, having a limit of quantification of 10 pg/mL. Serum concentrations of hepcidin-25 measured by ELISA correlated with hepcidin-25 concentrations measured by using an independent LC-MS assay. Hepcidin-25 concentrations were increased in 34 patients with cancer (median 54.8 µg/L, 25% - 75% range 23.2 - 93.5 µg/L,) and 76 with rheumatoid arthritis (median 10.6 µg/L, 25% - 75% range 5.9 - 18.4 µg/L,) compared with 100 healthy individuals (median 1.20 µg/L, 25% - 75% range 0.42 - 3.07 µg/L.

This sandwich ELISA could also be used to help diagnose iron deficiency anemia in difficult cases in which it may coexist with anemia of chronic disease. In uncomplicated iron deficiency, hepcidin concentrations would be expected to be quite low, whereas in anemia of chronic disease without coexisting iron deficiency, hepcidin concentrations would be expected to be increased. In patients with anemia of chronic disease, a relatively low serum hepcidin concentration might also indicate the presence of coexisting iron deficiency. The study was published in September 2010 in Clinical Chemistry.

Related Links:

Eli Lilly and Company



Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automatic Hematology Analyzer
DH-800 Series
ESR Analyzer
TEST1 2.0

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more